Juan Carlos Carrasco-Giménez

Juan Carlos Carrasco-Giménez on Linkedin

Juan Carlos Carrasco-Giménez is a Data Scientist and Product Manager holding a BSc. and MSc. in Industrial Engineering (University of Málaga), completed an Executive Program in Big Data and Business Analytics (EOI Business School), Executive Program in Digital Transformation (EOI Business School), a Postgraduate Diploma in Advanced Methods of Applied Statistics (UNED) and is a Certified Scrum Master. At Asociacion De Investigacion En Inteligencia Artificial Para La Leucemia Peter Moss, Juan Carlos is part of the AI R&D team and Student Program Mentor.

Juan Carlos Carrasco-Giménez
Juan Carlos Carrasco-Giménez on Linkedin

Juan Carlos Carrasco-Giménez

AI R&D / Student Program Mentor
Data Science - Product Management Advisor
FOQUM

Juan Carlos Carrasco-Giménez is a Data Scientist and Product Manager. He is passionate about the contribution that Artificial Intelligence can produce in society for good. Juan Carlos holds a BSc. and MSc. in Industrial Engineering (University of Málaga), completed an Executive Program in Big Data and Business Analytics (EOI Business School), Executive Program in Digital Transformation (EOI Business School), a Postgraduate Diploma in Advanced Methods of Applied Statistics (UNED) and is a Certified Scrum Master.

He joined Asociacion De Investigacion En Inteligencia Artificial Para La Leucemia Peter Moss to contribute to the development of new products and AI algorithms with PyTorch and Fast.ai for Computer Vision and Time Series Analysis. He is also mentor at the Student Program where he shares his expertise developing innovative products, thanks to more than 10 years of experience within the high-tech transport industry.

Leukemia AI Research

De Asociacion De Investigation En Intelligencia Artificial Para La Leucemia Peter Moss is a non profit research association dedicated to researching into the Artificial Intelligence and other modern technologies, and how they can be used in the fight against Leukemia and other blood cancers.

| |